MOBILE VIEW  | 

HYMENOPTERA STINGS

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Hymenoptera belong to a large group of insects that includes ants, bees, wasps, yellow jackets, and hornets. The term Hymenoptera refers to the membranous wings (2 pairs) that characterize these insects (Reisman & Livingston, 1992).
    B) Female bees, wasps, hornets, yellow jackets, and some ants (eg, imported fire ant) possess a venomous sting at the end of their abdomens.

Specific Substances

    1) Africanized honeybee (Apis mellifera scutellata)
    2) Apoidea (bees)
    3) Bees (Hymenoptera stings)
    4) Bee stings (hymenoptera stings)
    5) European hornet (Vespa crabro)
    6) European wasp (Vespula germanica)
    7) Honeybee (Apis mellifera)
    8) Hornet stings (hymenoptera stings)
    9) Japanese hornet (Vespa mandarinia)
    10) Paper wasp (Polistes annularis; Ropalidia greparia)
    11) Stings- bee, wasp, hornet or yellow jacket (hymenoptera stings)
    12) Vespoidea (wasps, hornets, and yellow jackets)
    13) Wasp stings (hymenoptera stings)
    14) White-faced hornet (Dolichovespula maculata)
    15) Yellow hornet (Dolichovespula arenaria)
    16) Yellow jacket stings (hymenoptera stings)
    17) Yellow jacket (Vespula pensylvanica)

Available Forms Sources

    A) FORMS
    1) Two major families within the Hymenoptera order of insects are: Vespids, which include yellow jackets, hornets, Polistes wasp; and Apids, which include the European honeybee and the Africanized honeybee (Reisman & Livingston, 1992).
    2) Hymenoptera with known venom composition (King, 1990):
    COMMON NAMEGENUS AND SPECIES
    HoneybeeApis mellifera
    Africanized honeybeeApis mellifera scutellata
    Paper waspPolistes annularis*; Ropalidia greparia
    Yellow jacketVespula pensylvanica*
    White-faced hornet (bald-faced hornet)Dolichovespula maculata
    Yellow hornetDolichovespula arenaria
    European hornetVespa crabro
    European waspVespula germanica
    Japanese hornetVespa mandarinia
    *Within this genus there are several other species with different geographic distributions.

    B) USES
    1) APITHERAPY
    a) Practiced in some parts of the world. Bee venom herbals are used by the Chinese in an ointment for remitting the pain of arthritis; in a cream for a mammogenic effect; and as bee venom eye drops in ophthalmia (Zhou, 1990).
    b) Scientific justification for the effectiveness of apitherapy is lacking (Banks & Shipolini, 1986).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: (Classification of species): The order Hymenoptera includes honeybees, bumblebees, yellow jacket hornets, wasps, and fire ants. Envenomation may cause allergic reactions, local effects, or systemic poisoning.
    B) EPIDEMIOLOGY: Hymenoptera stings are extremely common. Approximately 40 deaths per year are secondary to hymenoptera stings. The majority of these deaths are from anaphylaxis.
    C) TOXICOLOGY: Significant and active components in hymenoptera venom include melittin, hyaluronidase, phospholipase A2, apamin, and adolapin. These proteins cause cellular injury and elicit inflammatory response in the host. Antigen 5 and phospholipase A2 are also allergens and trigger histamine release.
    D) WITH POISONING/EXPOSURE
    1) NONALLERGIC LOCAL REACTION: The normal local reaction includes a wheal formation accompanied by pain, irritation, itching, and redness at the site of the sting. Symptoms generally resolve within a few hours. Even this normal degree of reactivity can be troublesome if around the nose or eyes. Stings in the mouth or throat may be especially dangerous because local edema may cause respiratory obstruction. These reactions are not IgE-mediated, but likely represent a response to toxic and inflammatory venom components such as vasoactive amines and peptides.
    2) TOXIC REACTIONS: Occur as a result of multiple stings when cumulative doses of toxins cause systemic poisoning.
    a) Manifestations include edema, fatigue, vomiting, diarrhea, headache, hyporeflexia, slurred speech, hypertension, tachycardia, hypotension, seizures, coma, rhabdomyolysis, and acute renal failure.
    b) Delayed toxic reactions are rare, but do occur. Such patients are asymptomatic after a massive bee envenomation, with normal initial laboratory results, but later develop laboratory evidence of hemolysis, coagulopathy, thrombocytopenia, rhabdomyolysis, liver dysfunction, and disseminated intravascular coagulation.
    3) HYPERSENSITIVITY REACTIONS: Allergies to venom protein allergens are not dose-dependent. Even 1 sting may cause a serious reaction in a sensitive individual. A risk factor in the development of Hymenoptera venom allergy may be a short interval (less than 2 months) between the innocuous sting and the successive sting.
    a) LOCAL: The pain of a Hymenoptera sting and extensive local swelling, often exceeding 10 cm, may persist for several days. Large local reactions do not predict progression to systemic reactions. The risk of eventual anaphylaxis in such individuals is only 5% to 10%, despite the presence of venom-specific IgE.
    b) SYSTEMIC: The systemic allergic reactions that may occur within 30 minutes of a sting include cutaneous (generalized urticaria, erythema, pruritus, and angioedema), respiratory (edema of the tongue, epiglottis, and larynx; bronchial constriction causing dyspnea, stridor, dysphagia, or wheezing), and/or vascular symptoms (cardiovascular collapse, hypotension, and loss of consciousness). The cause of death is usually respiratory obstruction, cardiovascular collapse, or both.
    4) SUBSEQUENT STINGS: Individuals who have had an anaphylactic reaction to an Hymenoptera sting have a 35% to 60% chance of developing anaphylaxis from subsequent stings by an identical insect.
    5) DELAYED TOXICITY: Patients with multiple stings may experience delayed toxicity, resembling serum sickness, that can be life-threatening. Early symptoms include rhabdomyolysis, elevated liver enzymes, and mildly abnormal coagulation tests, which peak in the first 1 to 3 days following the accident. A gradual deterioration of renal function peaks 4 to 9 days after the accident, and kidney injury may be severe enough to warrant dialysis. Mild to moderate anemia is the last clinical finding, occurring 4 to 13 days after the accident. Complete recovery is expected for patients who survive the initial and latter phases of toxicity.

Laboratory Monitoring

    A) Monitor vital signs, pulse oximetry and continuous cardiac monitoring.
    B) Monitor CBC, basic metabolic profile, liver enzymes, CK, INR, PTT, urinalysis and lactate in patients with multiple stings.
    C) Diagnostic procedures usually involve intradermal tests with various dilutions of Hymenoptera venoms. Most individuals with histories of hypersensitivity to Hymenoptera stings have positive venom skin tests. Whole body extracts of insects are no longer used in this procedure.
    D) The radioallergoabsorbent test (RAST) is an "in vitro" method that measures the quantity of venom-specific antibodies in the patient's serum. It is used as an adjunct to the venom skin test.

Treatment Overview

    0.4.7) BITES/STINGS
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Local application of ice packs at the sting site for 15 minutes every 30 minutes may decrease the intensity of swelling. Antihistamines may help reduce urticaria.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Treat vomiting with antiemetics. Treat hypotension with intravenous 0.9% saline, add vasopressors if hypotension persists. Treat seizures with benzodiazepines, add propofol or barbiturates if seizures persist or recur. Treat rhabdomyolysis with aggressive hydration, maintain urine output of 2 to 3 ml/kg/hr.
    C) DECONTAMINATION
    1) PREHOSPITAL: Manually remove the sting shafts with their commonly attached venom sacs as soon as possible, using a blunt-edged device. Avoid squeezing the stinger or venom sac. Wash the sting area with soap and water.
    2) HOSPITAL: Manually remove the sting shafts with their commonly attached venom sacs as soon as possible, using a blunt-edged device. Avoid squeezing the stinger or venom sac. Wash the sting area with soap and water.
    D) AIRWAY MANAGEMENT
    1) Early intubation is recommended if signs of airway obstruction starts to develop to avoid a difficult intubation.
    E) ANTIVENOM
    1) None.
    F) ACUTE ALLERGIC REACTION
    1) Antihistamines with or without inhaled beta agonists, corticosteroids or epinephrine. For severe reactions, administer oxygen, aggressive airway management, antihistamines, epinephrine, corticosteroids, ECG monitoring, and IV fluids.
    G) HYPOTENSIVE EPISODE
    1) Treat hypotension with intravenous 0.9% saline, add vasopressors (dopamine, norepinephrine) if hypotension persists.
    H) PATIENT DISPOSITION
    1) HOME MANAGEMENT: Patients with a small number of stings, who do not develop evidence of an allergic reaction, can be managed at home. Manually remove the sting shafts with their commonly attached venom sacs as soon as possible. If possible, use a key, piece of cardboard or other blunt-edged device. Avoid squeezing the stinger or venom sac. Local application of ice packs at the sting site for 15 minutes every 30 minutes may decrease the intensity of swelling. Over the counter antihistamines may reduce pruritus and swelling.
    2) OBSERVATION CRITERIA: Patients with multiple stings, and those with evidence of or a history of anaphylaxis should be referred to a healthcare facility. Any patient sustaining 50 stings or more should be observed for at least 6 hours with laboratory evaluation on presentation and at the end of observation for hemolysis, thrombocytopenia, liver and renal function abnormalities, increased CK and rhabdomyolysis. Patients with multiple stings who look well after 6 to 8 hours observation and have normal laboratory evaluations can be discharged but should have repeat laboratory evaluation in 24 to 48 hours to detect delayed effects.
    3) ADMISSION CRITERIA: Those patients who develop severe anaphylaxis require admission and continued monitoring for late development of symptoms even after therapy is administered. Patients with evidence of hemolysis, rhabdomyolysis or systemic effects after multiple stings should be admitted.
    4) CONSULT CRITERIA: Consult a poison center or medical toxicologist for assistance in managing patients with severe signs and symptoms.
    I) PITFALLS
    1) Failure to observe patients with multiple stings (greater than 50) for late toxicity.
    J) DIFFERENTIAL DIAGNOSIS
    1) Anaphylaxis to various insects, objects, medications, or plants

Range Of Toxicity

    A) The range of toxicity from a nonimmunologic reaction is venom dose-dependent and extends from trivial to death in the case of massive attacks.
    B) In toddlers, as few as 7 stings have caused systemic effects. Twenty or more stings from vespid Hymenoptera (eg, wasps) may cause severe morbidity or death. Although more than 1000 honeybee stings have been incurred with survival, 150 or more honey bee stings have caused severe morbidity and death. One man who endured more than 2000 Africanized bee stings survived without sequelae despite multiple organ failure.
    C) Massive attacks by bees can result in up to several thousand stings, while massive wasp attacks range from ten to hundreds of stings.

Summary Of Exposure

    A) USES: (Classification of species): The order Hymenoptera includes honeybees, bumblebees, yellow jacket hornets, wasps, and fire ants. Envenomation may cause allergic reactions, local effects, or systemic poisoning.
    B) EPIDEMIOLOGY: Hymenoptera stings are extremely common. Approximately 40 deaths per year are secondary to hymenoptera stings. The majority of these deaths are from anaphylaxis.
    C) TOXICOLOGY: Significant and active components in hymenoptera venom include melittin, hyaluronidase, phospholipase A2, apamin, and adolapin. These proteins cause cellular injury and elicit inflammatory response in the host. Antigen 5 and phospholipase A2 are also allergens and trigger histamine release.
    D) WITH POISONING/EXPOSURE
    1) NONALLERGIC LOCAL REACTION: The normal local reaction includes a wheal formation accompanied by pain, irritation, itching, and redness at the site of the sting. Symptoms generally resolve within a few hours. Even this normal degree of reactivity can be troublesome if around the nose or eyes. Stings in the mouth or throat may be especially dangerous because local edema may cause respiratory obstruction. These reactions are not IgE-mediated, but likely represent a response to toxic and inflammatory venom components such as vasoactive amines and peptides.
    2) TOXIC REACTIONS: Occur as a result of multiple stings when cumulative doses of toxins cause systemic poisoning.
    a) Manifestations include edema, fatigue, vomiting, diarrhea, headache, hyporeflexia, slurred speech, hypertension, tachycardia, hypotension, seizures, coma, rhabdomyolysis, and acute renal failure.
    b) Delayed toxic reactions are rare, but do occur. Such patients are asymptomatic after a massive bee envenomation, with normal initial laboratory results, but later develop laboratory evidence of hemolysis, coagulopathy, thrombocytopenia, rhabdomyolysis, liver dysfunction, and disseminated intravascular coagulation.
    3) HYPERSENSITIVITY REACTIONS: Allergies to venom protein allergens are not dose-dependent. Even 1 sting may cause a serious reaction in a sensitive individual. A risk factor in the development of Hymenoptera venom allergy may be a short interval (less than 2 months) between the innocuous sting and the successive sting.
    a) LOCAL: The pain of a Hymenoptera sting and extensive local swelling, often exceeding 10 cm, may persist for several days. Large local reactions do not predict progression to systemic reactions. The risk of eventual anaphylaxis in such individuals is only 5% to 10%, despite the presence of venom-specific IgE.
    b) SYSTEMIC: The systemic allergic reactions that may occur within 30 minutes of a sting include cutaneous (generalized urticaria, erythema, pruritus, and angioedema), respiratory (edema of the tongue, epiglottis, and larynx; bronchial constriction causing dyspnea, stridor, dysphagia, or wheezing), and/or vascular symptoms (cardiovascular collapse, hypotension, and loss of consciousness). The cause of death is usually respiratory obstruction, cardiovascular collapse, or both.
    4) SUBSEQUENT STINGS: Individuals who have had an anaphylactic reaction to an Hymenoptera sting have a 35% to 60% chance of developing anaphylaxis from subsequent stings by an identical insect.
    5) DELAYED TOXICITY: Patients with multiple stings may experience delayed toxicity, resembling serum sickness, that can be life-threatening. Early symptoms include rhabdomyolysis, elevated liver enzymes, and mildly abnormal coagulation tests, which peak in the first 1 to 3 days following the accident. A gradual deterioration of renal function peaks 4 to 9 days after the accident, and kidney injury may be severe enough to warrant dialysis. Mild to moderate anemia is the last clinical finding, occurring 4 to 13 days after the accident. Complete recovery is expected for patients who survive the initial and latter phases of toxicity.

Vital Signs

    3.3.3) TEMPERATURE
    A) WITH POISONING/EXPOSURE
    1) FEVER has been reported (Betten et al, 2006; Watemberg et al, 1995; Franca et al, 1994) .

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) CORNEAL STINGS
    a) Corneal edema, ulceration, hyperemia, pain, scarring, linear keratitis, and secondary bacterial keratitis can occur (Chinwattanakul et al, 2006; Arcieri et al, 2002; Miyashita, 1992; Chen & Richardson, 1986; Meija et al, 1986; Smolin & Wong, 1981)
    2) EXTERNAL EYE STINGS
    a) Pain, swelling, tearing, hyperemia, conjunctival chemosis can occur (Miyashita, 1992; Smolin & Wong, 1981).
    3) RARE EFFECTS
    a) Heterochromia-iridis, internal ophthalmoplegia, punctate subcapsular opacities (Chinwattanakul et al, 2006; Song & Wray, 1991; Singh, 1984) ; retrobulbar neuritis (Goldstein et al, 1960); optic neuritis; degeneration of retinal ganglion rarely occur.
    b) OCULAR TRAUMA
    1) CASE SERIES: A small case series reviewed 5 patients who had suffered ocular trauma caused by Hymenopteran insects (1 bee sting and 4 wasp stings). In the patient with the bee sting, slit-lamp biomicroscopy revealed right eye conjunctival hyperemia 2+/4+, corneal edema 1+/4+, with the presence of a foreign body, broken stinger from the bee, in the superior deep cornea protruding into the anterior chamber. Four patients with wasp stings developed persistent corneal decompensation. Case 1 patient had inferior vascularization of the stroma, intense corneal edema, inferior iris atrophy, and total cataract in his left eye, requiring surgical treatment. Case 2 patient with a wasp sting experienced corneal edema 3+/4+ and total cataract, requiring surgical treatment. The histopathologic exam of the left eye of the case 3 patient showed focal thickening of the corneal epithelium, discontinuous Bowman's layer and Descemet's membrane, and the stroma with fibrous areas, edema, and vascularization. In the case 4, biomicroscopy of the right eye showed corneal edema 3+/4+ in the stroma, with folds in Descemet's membrane, inferior iris atrophy and anterior chamber inflammatory reaction 3+/4+ (Arcieri et al, 2002).
    c) BLINDNESS
    1) CASE REPORT: A 76-year-old man experienced long-term blindness in his right eye after he was stung by a wasp. The man presented to a private clinic 4 days after the event with severe pain and eyelid edema. Slit-lamp biomicroscopy revealed severe conjunctival injection, chemosis, and a total epithelial defect with severe corneal edema and dense stromal infiltration. A barb track was found at 9 o'clock in the mid-peripheral cornea, but there were no leaks and no physical wasp barb to remove. Ultrasonography showed serous retinal detachment and further testing showed no surviving visual field. The patient was treated with antibiotics and corticosteroids; however, his vision was permanently lost in the right eye(Kim et al, 2011).
    d) OPHTHALMOPARESIS
    1) CASE REPORT: An 8-year-old boy developed cavernous sinus syndrome and bilateral cerebral infarcts secondary to a wasp sting on his right eyebrow and nasal bridge. The child presented to the hospital with significant swelling of the right eye and the inability to open the right eyelid. The child developed hemiplegia and altered senses 8 days after the sting and was unable to move his upper and lower limbs 1 day later. MRI and CT imaging revealed infarcts in the left frontoparietal cortex, suggestive of bilateral cavernous sinus thrombosis, posterior limb of the left internal capsule and right subcortical region. Right ophthalmiac exam revealed complete ophthalmoplegia with total ptosis and dilated and fixed pupils along with total absence of eye movements in all directions. Left ophthalmic examination showed corneal ulcer, partial ptosis, and a reduced range of eye movement, particularly in outward direction and sluggish papillary reaction. He also exhibited left upper motor neuron type facial nerve palsy. The child regained consciousness after 15 days of treatment with antibiotics (systemic and topical), anticoagulants, and antiinflammatory eye drops. On final exam, the patient was able to move the left upper and lower limbs, and his eye swelling and ptosis had reduced, but right-sided complete ophthalmoplegia remained (Vidhate et al, 2011).
    3.4.6) THROAT
    A) WITH POISONING/EXPOSURE
    1) Throat stings can cause life-threatening pharyngeal edema and respiratory obstruction, and may occur when a bee or hornet is swallowed such as with a soft drink or juice (Shah & Tsang, 1998; Anon, 1988; Jones & Joy, 1988; McLean, 1987; Butterton & Clawson-Simons, 1987) .

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) MYOCARDIAL INFARCTION
    1) WITH POISONING/EXPOSURE
    a) Cardiac arrhythmias and myocardial infarction following Hymenoptera stings are rare and are usually associated with the anaphylactic response. They are primarily associated with stings in older patients with preexisting heart disease (Muller et al, 1989; Jones & Joy, 1988; Levine, 1976) but also may develop in young adults (Freye & Ehrlich, 1989).
    b) CASE REPORT: A 69-year-old man with minimal cardiac risk factors developed second-degree heart block, mild hypotension (92/40), respiratory failure, and an ST elevation myocardial infarction demonstrated on ECG after a bee sting. He was not treated with epinephrine. The patient was initially intubated and taken to the catheterization lab, which revealed minimal coronary artery disease with no acute structural lesions found. A complete recovery was made 3 days later (Valkanas et al, 2007).
    c) CASE REPORT: A 58-year-old man developed anaphylaxis with dizziness, chest pain, flushing, diaphoresis, and erythema minutes after a wasp sting to the left elbow. EMS arrived and found the patient hypotensive (86/54 mm Hg), with ECG showing ST elevation; inferior STEMI was diagnosed. Aspirin, clopidogrel, diphenhydramine, and methylprednisone were administered, but no epinephrine was given. The patient was taken to the catheterization lab on arrival and normal coronary arteries were found. The patient made a rapid recovery and was discharged the following day (Rekik et al, 2009).
    d) Cardiorespiratory arrest has been reported after multiple stings from Africanized honey bees (Franca et al, 1994).
    B) HEART FAILURE
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 19-year-old patient developed severe myocardial depression and pulmonary edema associated with anaphylaxis from a sting (Otero et al, 1991).
    C) HYPERTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) Hypertension has occurred in children with multiple bee stings (Franca et al, 1994; Meszaros, 1990) and in an adult with multiple wasp stings (Chen et al, 2004).
    D) HYPOTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) Hypotension has developed several days after multiple Africanized honey bee stings, which resulted in death (Franca et al, 1994).
    b) A 30-year-old man developed persistent hypotension (average blood pressure 80/40 mm Hg), unresponsive to administration of dopamine and IV fluids, after receiving more than 2000 Africanized honeybee stings (Diaz-Sanchez et al, 1998).
    E) TACHYARRHYTHMIA
    1) WITH POISONING/EXPOSURE
    a) Tachycardia has been reported following multiple Africanized honeybee stings (Betten et al, 2006; Diaz-Sanchez et al, 1998; Franca et al, 1994).
    F) GIANT CELL ARTERITIS
    1) WITH POISONING/EXPOSURE
    a) GIANT CELL ARTERITIS: A 71-year-old man stung by Hymenoptera on the knee developed progressively worse bilateral orbital pain, which later localized over the left temporal artery. Histologic samples showed thickening of the arterial wall with infiltration of lymphocytes and histiocytes. Serum IgE levels were elevated (713 Units/mL) and IgE specific for yellow jacket was extremely high. Symptoms improved with prednisone therapy (Schoen, 1998).
    G) THROMBOSIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 71-year-old woman was stung by a swarm of wasps. She developed right-sided facial weakness and left-sided limb weakness 24 hours later and then developed paraplegia. On examination, she had cold legs with decreased dorsalis pedis pulses and hyporeflexia of the legs. D-dimer level was elevated at 1151 ng/dL (normal < 500 ng/dL), as were fibrinogen degradation products of 4 mcg/mL (normal <1 mcg/mL). An arteriogram showed total occlusion of the infrarenal aorta without collateral circulation. Approximately 80 hours postenvenomation, the patient underwent an emergent thrombectomy (Chen et al, 2004).
    b) CASE REPORT: A 40-year-old man developed a thrombus occluding the lower 3 arteries of the left leg after experiencing approximately 10 bee stings. The patient developed paresthesias in the affected limb the night after the event, and cyanosis appeared in the first and second left toes approximately 24 hours after presentation. Genetic testing revealed the patient had an undiagnosed anomaly that predisposed him to thrombosis (homozygous mutation in the methylenetetrahydrofolate reductase gene (A1298C) and heterozygous mutation in the prothrombin gene (G20210A)). The patient was treated with anticoagulant and antiplatelet therapy (warfarin and aspirin), and the thrombus resolved without further sequelae (El Husseiny et al, 2011).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) EDEMA OF LARYNX
    1) WITH POISONING/EXPOSURE
    a) Airway obstruction may occur (Anon, 1988; Jones & Joy, 1988; McLean, 1987; Butterton & Clawson-Simons, 1987).
    B) APNEA
    1) WITH POISONING/EXPOSURE
    a) Apnea, respiratory insufficiency, and/or cardiopulmonary arrest have been reported in patients who became comatose after receiving multiple stings (Watemberg et al, 1995; Franca et al, 1994) .
    C) DYSPNEA
    1) WITH POISONING/EXPOSURE
    a) Dyspnea and tachypnea have been reported in patients with anaphylaxis and those receiving multiple stings (Betten et al, 2006; Speach et al, 1998; Franca et al, 1994; Otero et al, 1991) .

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) COMA
    1) WITH POISONING/EXPOSURE
    a) Coma has been reported in adults and children stung multiple times by Africanized honeybees (Iliev et al, 2010; Diaz-Sanchez et al, 1998; Franca et al, 1994) or hornets (Watemberg et al, 1995).
    B) SEIZURE
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Tonic-clonic seizures developed in a 3-year-old approximately 6 hours after more than 40 hornet stings (Watemberg et al, 1995).
    C) DISTURBANCE IN SPEECH
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: An initial effect in an adult was slurred speech 8 hours after being stung by hornets. His condition significantly deteriorated after 1 day, with the development of epidural and intracerebral hemorrhage and delayed peripheral neuropathy (Yao & Deng, 1994).
    D) HYPOREFLEXIA
    1) WITH POISONING/EXPOSURE
    a) Depressed deep tendon reflexes were reported in a fatal pediatric case of multiple hornet stings (Watemberg et al, 1995).
    E) ACUTE ALLERGIC REACTION
    1) WITH POISONING/EXPOSURE
    a) Delayed neurologic hypersensitivity reactions which rarely occur, but can be fatal, include CNS demyelination (Means et al, 1973) and delayed peripheral neuropathy (van Antwerpen et al, 1988).
    b) CASE REPORT: Headache, disorientation, and persistent memory loss occurred several days after anaphylaxis from a Hymenoptera sting (Mazza et al, 1991).
    c) CASE REPORT: Epidural and intracranial hemorrhage about 1 day after exposure, followed by sensory and distal axonal neuropathy identified on day 26, developed in an adult who developed disseminated intravascular coagulation after being stung by hornets (Yao & Deng, 1994).
    F) NEUROPATHY
    1) WITH POISONING/EXPOSURE
    a) A temporary brachial plexus block occurred following a bee sting on the right side of the neck (Hay et al, 1992).
    b) Two cases of temporary bilateral facial palsy have occurred as a result of Hymenoptera stings. One patient reported being stung on the thorax and the other on the arm (Raucq & Dupuis, 1998).
    c) CASE REPORT: A 6-year-old girl developed local pain and swelling, and then a progressive, symmetrical, ascending weakness of her lower extremities within 3 days after a honey-bee sting on her left thigh. Serial nerve conduction studies confirmed a diagnosis of acute motor axonal neuropathy. Following treatment with IV immunoglobulin (2 g/kg over 2 days), her symptoms gradually improved. On a follow-up visit 20 weeks later, she continued to have muscle weakness. She was able to walk unassisted but could not run or climb stairs. She continued to have regular physiotherapy (Saini, 2014).
    G) HEMICHOREA
    1) WITH POISONING/EXPOSURE
    a) POST-STROKE HEMICHOREA: A 50-year-old man with multiple bee stings (3 bee stings on both of his proximal tibia areas) experienced itching and 2 episodes of syncope and received an oral H1 blocker from a local clinic. The next day, he presented to an ED with itching, dyspnea, and lip swelling. He was treated with IV methylprednisolone, chlorpheniramine, ranitidine, and IM epinephrine (0.3 mg). About 27 hours after the bee stings, he developed a sudden onset of involuntary hyperkinetic movement (hemichorea) of the left leg. Diffusion magnetic resonance imaging of the patient showed right temporal lobe infarction. A right M2 inferior and superior division branch occlusion was observed in a brain computed tomography angiography. All pathologic findings were normal. Following treatment with aspirin, citicoline sodium, lorazepam, and haloperidol, his involuntary movements resolved the day after admission (An et al, 2014).
    H) CEREBROVASCULAR ACCIDENT
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 71-year-old woman was stung multiple times by wasps and, 24 hours later, developed right-sided mouth deviation and numbness and weakness of her left-sided extremities progressing to paraplegia. Physical examination showed generalized muscle tenderness, left hemiplegia, paraplegia, absent bilateral extensor plantar reflexes, and hyporeflexia of the lower extremities. An initial brain CT scan was normal; however, a brain CT scan, approximately 2 weeks later, showed a right middle cerebral artery infarction. The patient gradually recovered with supportive care (Chen et al, 2004).
    b) CASE REPORT: A 60-year-old man presented after being stung approximately 100 times on his face, head, and limbs. He was treated with antihistamines and subcutaneous epinephrine. Two hours after the incident, he developed left-sided hemiplegia and dysarthria. MRI showed ischemic changes in the frontal lobe, right temporoparietal area, and bilateral centrum semiovale. Aspirin, antiedema therapy, and low molecular weight heparin were given as treatment. At a follow-up 3 months later, the patient's dysarthria had resolved and slight left-sided hemiplegia remained (Temizoz et al, 2009).
    c) CASE REPORT: A 50-year-old man with multiple bee stings (3 bee stings on both of his proximal tibia areas) experienced itching and 2 episodes of syncope and received an oral H1 blocker from a local clinic. The next day, he presented to an ED with itching, dyspnea, and lip swelling. He was treated with IV methylprednisolone, chlorpheniramine, ranitidine, and IM epinephrine (0.3 mg). About 27 hours after the bee stings, he developed a sudden onset of involuntary hyperkinetic movement (hemichorea) of the left leg. Diffusion magnetic resonance imaging of the patient showed right temporal lobe infarction. A right M2 inferior and superior division branch occlusion was observed in a brain computed tomography angiography. All pathologic findings were normal. Following treatment with aspirin, citicoline sodium, lorazepam, and haloperidol, his involuntary movements resolved the day after admission (An et al, 2014).
    I) ANOXIC ENCEPHALOPATHY
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 30-year-old man was stung by a bee and suffered cardiorespiratory arrest. Upon emerging from coma he presented with severe apraxia secondary to hypoxic brain injury (Speach et al, 1998).
    J) MULTIPLE SCLEROSIS
    1) WITH POISONING/EXPOSURE
    a) Exacerbation of multiple sclerosis (MS) has been reported following wasp stings in a 41-year-old man. The authors speculated that a wasp sting in a nonallergic patient could raise serum levels of interferon gamma that might lead to a flare of MS symptoms (Dionne et al, 2000).
    K) CAVERNOUS SINUS SYNDROME
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: An 8-year-old boy developed cavernous sinus syndrome and bilateral cerebral infarcts secondary to a wasp sting on his right eyebrow and nasal bridge. The child presented to the hospital with significant swelling of the right eye and the inability to open the right eyelid. The child developed hemiplegia and altered senses 8 days after the sting and was unable to move his upper and lower limbs 1 day later. MRI and CT imaging revealed infarcts in the left frontoparietal cortex, suggestive of bilateral cavernous sinus thrombosis, posterior limb of the left internal capsule and right subcortical region. Right ophthalmiac exam revealed complete ophthalmoplegia with total ptosis and dilated and fixed pupils along with total absence of eye movements in all directions. Left ophthalmic examination showed corneal ulcer, partial ptosis, and a reduced range of eye movement, particularly in outward direction and sluggish papillary reaction. He also exhibited left upper motor neuron type facial nerve palsy. The child regained consciousness after 15 days of treatment with antibiotics (systemic and topical), anticoagulants, and antiinflammatory eye drops. On final exam, the patient was able to move the left upper and lower limbs, and his eye swelling and ptosis had reduced, but right-sided complete ophthalmoplegia remained (Vidhate et al, 2011).
    L) TETRAPARESIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 10-year-old boy developed severe peripheral quadriparesis and sphincteric disorder (urinary incontinence) within 40 hours after being stung by a wasp. Following supportive care, including corticosteroid therapy (dexamethasone 1 mg/kg/day IV in 4 divided doses for 4 days and then gradual reduction of the dose for the next 10 days), his condition gradually improved in the next 72 hours. About 3 weeks later, he was discharged with a diagnosis of toxo-allergic polyradiculoneuropathy caused by wasp sting (Banovcin et al, 2009).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) NAUSEA AND VOMITING
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Nausea and multiple episodes of vomiting occurred in a 13-year-old boy approximately 8 hours after having been stung by approximately 700 honey bees (Betten et al, 2006).

Hepatic

    3.9.2) CLINICAL EFFECTS
    A) HEPATIC NECROSIS
    1) WITH POISONING/EXPOSURE
    a) Hepatic necrosis has been detected upon autopsy in fatal cases of multiple honeybee (Franca et al, 1994) and hornet stings (Watemberg et al, 1995). Shock and anoxia may have contributed to the hepatic effects.
    B) LIVER ENZYMES ABNORMAL
    1) WITH POISONING/EXPOSURE
    a) Elevated liver function tests have occurred in patients with multiple bee (Betten et al, 2006; Diaz-Sanchez et al, 1998; Franca et al, 1994; Kini et al, 1994; Meszaros, 1990) , wasp (Chen et al, 2004), and hornet (Sakhuja et al, 1988) stings.
    C) TOXIC HEPATITIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 73-year-old woman with no known allergies was stung 518 times by a swarm of bees. One day later she was found unresponsive at home with massive soft tissue swelling, severe hypertension, and signs of pulmonary congestion. Despite supportive care, her condition deteriorated and she developed severe rhabdomyolysis, toxic hepatitis, and acute renal failure. Following further symptomatic therapy, including 7 sessions of hemodialysis, her condition gradually improved and she was discharged 20 days after presentation to the nephrology clinic. At this time, she developed hemorrhagic gastritis with melena and posthemorrhagic anemia, but was discharged 12 days later after her condition improved again. On a follow-up visit 6 months later, she had compensated polyarthrosis and hypertension (Iliev et al, 2010).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) ACUTE RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Acute renal failure has been associated with multiple Hymenoptera stings (eg, Africanized bees, yellow jackets, wasps); onset is within 24 to 48 hours of the sting (Iliev et al, 2010; Orletsky & Thomas, 2000b; Diaz-Sanchez et al, 1998; Deshmukh & Borse, 1996; Watemberg et al, 1995; Franca et al, 1994; Beccari et al, 1992; Munoz-Arizpe et al, 1992; Nace, 1992; Elgart, 1990; Sakhuja et al, 1988; Meija et al, 1986; Bousquet et al, 1984).
    b) PATHOGENESIS: Intravascular hemolysis and/or rhabdomyolysis may have been responsible for nephrotoxicity in some of the above patients; however, a direct toxic effect of the venom on renal tubules in the absence of hemolysis or rhabdomyolysis has occurred (Beccari et al, 1992; Nace, 1992).
    c) CASE REPORT: A 73-year-old woman with no known allergies was stung 518 times by a swarm of bees. One day later she was found unresponsive at home with massive soft tissue swelling, severe hypertension, and signs of pulmonary congestion. Despite supportive care, her condition deteriorated and she developed severe rhabdomyolysis, toxic hepatitis, and acute renal failure. Following further symptomatic therapy, including 7 sessions of hemodialysis, her condition gradually improved. After 20 days in an acute care hospital she was discharged to a nephrology clinic where she subsequently developed hemorrhagic gastritis with melena. She remained in this facility for 12 days and was discharged. On a follow-up visit 6 months later, she had compensated polyarthrosis and hypertension (Iliev et al, 2010).
    d) CASE REPORT: A 13-year-old boy developed facial swelling, nausea, vomiting, tachycardia, fever, and hypotension approximately 8 to 12 hours after having been stung by approximately 700 bees. Laboratory studies revealed elevated serum creatinine (3.1 mg/dL), BUN (38 mg/dL), and creatine phosphokinase (32,520 ng/mL) levels. Urinalysis showed hematuria and proteinuria. During the initial 24 hours of monitoring, his urine output was minimal (approximately 300 mL), but improved with hydration and administration of diuretics. Forty-eight hours after envenomation, the patient's creatine phosphokinase level peaked at 106,720 ng/mL, but with continued supportive care, his rhabdomyolysis and associated renal insufficiency improved rapidly and he was discharged on hospital day 6 (approximately 7 days post-envenomation) (Betten et al, 2006).
    e) CASE SERIES: Among 45 pediatric cases of wasp stings, 7 developed acute renal failure secondary to hemolysis and/or rhabdomyolysis. One patient died prior to therapy start due to hyperkalemia (K=8.7 mEq/L); the other cases recovered following peritoneal dialysis. All 6 surviving patients developed volume overload, 4 had hypertension, and 5 had oliguria for 9 to 15 days. Electrolyte imbalances (hyponatremia, hyperkalemia) and metabolic acidosis occurred in all patients. Peak serum creatinine levels ranged from 4 to 11.9 mg/dL, and dialysis was performed for 3 to 15 days (Vachvanichsanong & Dissaneewate, 2009).
    B) ALBUMINURIA
    1) WITH POISONING/EXPOSURE
    a) Proteinuria has occurred in cases of multiple bee stings in children (Betten et al, 2006; Meszaros, 1990).

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) HEMOLYSIS
    1) WITH POISONING/EXPOSURE
    a) Hemolysis may occur following multiple hornet (Iliev et al, 2010; Sakhuja et al, 1988), Africanized honeybee (Franca et al, 1994; Munoz-Arizpe et al, 1992; Meija et al, 1986) , and yellow jacket (Bousquet et al, 1984) stings.
    b) CASE REPORT: Disseminated intravascular hemolysis occurred in an adult following multiple hornet stings (Yao & Deng, 1994).
    B) THROMBOCYTOPENIC DISORDER
    1) WITH POISONING/EXPOSURE
    a) Thrombocytopenia has been reported following multiple bee (Munoz-Arizpe et al, 1992; Meszaros, 1990), hornet (Sakhuja et al, 1988), wasp (Chen et al, 2004), and Africanized honeybee stings (Orletsky & Thomas, 2000b).
    b) Thrombocytopenia is thought to be due to a direct action of the Hymenoptera venom on platelets (Bousquet et al, 1984).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) PAIN
    1) WITH POISONING/EXPOSURE
    a) The normal reactions to a sting include localized pain, irritation, itching, redness, and swelling at the site of the sting; these effects often resolve within a few hours (Chen et al, 2004; Jerrard, 1996).
    b) These effects are not IgE-mediated, but likely represent a response to toxic and inflammatory venom components such as vasoactive amines and peptides.
    c) CASE REPORT: Diffuse pain and upper-body swelling, including the scalp, face, neck, chest, upper extremities, and abdomen, occurred in a 13-year-old boy 8 hours after having been stung by approximately 700 honeybees. With supportive care, the patient gradually improved and was discharged on hospital day 6 (approximately 7 days post envenomation) with minimal pain and significantly decreased facial and upper-body swelling (Betten et al, 2006).
    B) SKIN NECROSIS
    1) WITH POISONING/EXPOSURE
    a) Retention of a bee stinger for 4 months resulted in epidermal necrosis, marked pseudoepitheliomatous hyperplasia, and eosinophilic infiltration of the dermis (Hur et al, 1991).
    b) CASE SERIES: A Japanese literature review evaluated 15 cases of multiple organ failure following multiple wasp (Vespa mandarinia) stings (17 to 100 stings). Thirteen of the 15 cases developed skin hemorrhage or necrosis prior to the development of organ failure, and the authors speculate a relationship may exist between the cutaneous hemorrhage or necrosis and predictive organ injury (Yanagawa et al, 2007).
    C) CELLULITIS
    1) WITH POISONING/EXPOSURE
    a) Severe cutaneous infection and cellulitis have occurred after stings from yellow jackets and wasps, which may pick up virulent bacteria while foraging on decaying animal and vegetable matter (Yungingen, 1993) (Singh et al, 1992; Thiel, 1992).
    D) GRANULOMA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: An eosinophilic foreign-body granuloma and an IgE pseudolymphoma was accompanied by severe edema on the forehead of a man after receiving multiple bee stings to the area (Hermes et al, 1994).
    E) HYPERSENSITIVITY REACTION
    1) WITH POISONING/EXPOSURE
    a) Large local allergic reactions involve pain and extensive local swelling, which often exceeds 10 cm and may persist for several days (Jerrard, 1996a; Reisman & Livingston, 1992; Golden, 1987) .
    b) Large local reactions do not predict progression to systemic reactions. The risk of eventual anaphylaxis in such individuals is only 5% to 10%, despite the presence of venom-specific IgE (Jerrard, 1996a; Li & Yunginger, 1992; Golden, 1987) .
    c) A risk factor in the development of Hymenoptera venom allergy may be a short interval (less than 2 months) between the innocuous sting and the successive sting (Pucci et al, 1994).
    F) ALOPECIA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 35-year-old woman reported diffuse hair loss 4 months after a life-threatening encounter with multiple honeybee stings. The diagnosis of telogen effluvium was made (Sharma et al, 1997).
    G) EDEMA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Diffuse pain and upper-body swelling, including the scalp, face, neck, chest, upper extremities, and abdomen, occurred in a 13-year-old boy 8 hours after having been stung by approximately 700 honey bees. With supportive care, the patient gradually improved and was discharged on hospital day 6 (approximately 7 days post envenomation) with minimal pain and significantly decreased facial and upper-body swelling (Betten et al, 2006).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) JOINT PAIN
    1) WITH POISONING/EXPOSURE
    a) Arthralgia often accompanies allergic serum sickness-type reactions and may have a delayed onset following Hymenoptera stings (Reisman & Livingston, 1989).
    B) RHABDOMYOLYSIS
    1) WITH POISONING/EXPOSURE
    a) Rhabdomyolysis has been reported following multiple hornet, yellow jacket, and Africanized honeybee stings (Iliev et al, 2010; Vachvanichsanong & Dissaneewate, 2009; Orletsky & Thomas, 2000b; Franca et al, 1994; Sakhuja et al, 1988; Bousquet et al, 1984) .
    b) CASE REPORT: A 73-year-old woman with no known allergies was stung 518 times by a swarm of bees. One day later she was found unresponsive at home with massive soft tissue swelling, severe hypertension, and signs of pulmonary congestion. Despite supportive care, her condition deteriorated and she developed severe rhabdomyolysis, toxic hepatitis, and acute renal failure. Following further symptomatic therapy, including 7 sessions of hemodialysis, her condition gradually improved and she was discharged 20 days after presentation to the nephrology clinic. At this time, she developed hemorrhagic gastritis with melena and posthemorrhagic anemia, but was discharged 12 days later after her condition improved again. On a follow-up visit 6 months later, she had compensated polyarthrosis and hypertension (Iliev et al, 2010).
    c) CASE REPORT: A 13-year-old boy developed facial swelling, nausea, vomiting, tachycardia, fever, and hypotension approximately 8 to 12 hours after having been stung by approximately 700 bees. Laboratory studies showed elevated serum creatinine (3.1 mg/dL), BUN (38 mg/dL), and creatine phosphokinase (32,520 ng/mL) levels. During the initial 24 hours of monitoring, his urine output was minimal (approximately 300 mL), but improved with hydration and administration of diuretics. Forty-eight hours after envenomation, the patient's creatine phosphokinase level peaked at 106,720 ng/mL, but with continued supportive care, his rhabdomyolysis and associated renal insufficiency improved rapidly and he was discharged on hospital day 6 (approximately 7 days post envenomation) (Betten et al, 2006).
    C) ARTHRITIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: An infant developed arthritis with osteochondral destruction in a finger following bee stings. Bloody fluid was aspirated from the distal interphalangeal (DIP) joint shortly after the sting. The affected area was also treated with steroid ointment. Two years later, the DIP joint was still swollen, unstable, and tender, with slight deviation to the radial side. Radiography showed an osteolytic lesion in the distal-volar end of the middle phalanx and reduced joint space. Microscopy of a resected specimen, obtained surgically, showed fibrous granulation tissue with infiltration of inflammation cells, and without foreign bodies or epidermal tissues. Three years after the surgery, the bone defect had decreased, leaving an irregular subchondral bone surface and narrowing of the joint space (Haga et al, 2006).
    3.15.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) MUSCLE NECROSIS
    a) Africanized bee venom caused widespread rhabdomyonecrosis in rats injected IM or IV with the venom (Azevedo-Marques et al, 1992).

Immunologic

    3.19.2) CLINICAL EFFECTS
    A) ANAPHYLACTOID REACTION
    1) WITH POISONING/EXPOSURE
    a) SUMMARY (Li & Yunginger, 1992; Kaliner, 1984):
    1) The spectrum of anaphylactic responses to Hymenoptera stings range from localized to systemic. Systemic anaphylaxis may lead to anaphylactic shock and death if untreated.
    2) The necessary components of the anaphylactic response are:
    a) A sensitizing venom antigen introduced systemically by the sting.
    b) An IgE antibody response resulting in systemic sensitization of mast cells and basophils.
    c) of the sensitizing antigen by a subsequent sting.
    d) Mast cell degranulation with systemic release of mediators, particularly histamine and tryptase.
    e) Mediator-induced pathologic responses manifested as anaphylaxis.
    b) PATHOGENESIS: Histamine and tryptase play a primary role as a mediators of immediate hypersensitivity responses (Van der Linden et al, 1992).
    1) Many of the clinical changes occurring in anaphylaxis involve the action of histamine on H-1 and H-2 receptors (Lieberman, 1990; Casale, 1984; Kaliner, 1984).
    a) Erythema, edema, and pruritus associated with urticaria are mediated by the action of histamine on H-1 and H-2 receptors (Moscati & Moore, 1990).
    b) Chronotropic effects of histamine are mediated by H-2 receptor activation of cardiac adrenergic nerves (Schellenberg et al, 1989).
    c) Additional studies are needed to clarify the degree of involvement of these two receptor classes in allergic reactions.
    2) Although its precise involvement in hypersensitivity reactions is uncertain, tryptase is thought to enhance the action of histamine on bronchial and vascular smooth muscle (Van der Linden et al, 1992; Schwartz et al, 1990). Elevated postmortem tryptase levels may serve as a marker for fatal hymenoptera-induced anaphylaxis (Yunginger et al, 1991).
    c) ANAPHYLACTOID REACTION: Not all anaphylactic reactions are IgE-mediated. Some reactions are of the anaphylactoid type, which may involve the direct action of venom components such as mast cell degranulating peptides (Fricker et al, 1997; Lomnitzer et al, 1988). Anaphylactoid shock (not IgE mediated) following wasp stings has occurred in patients with systemic mastocytosis (Kors et al, 1993).
    d) INCIDENCE OF ALLERGIC SENSITIZATION: Occurs in more than 30% of individuals who are stung; disappears 2 to 3 years after a sting in 40% of cases (Golden et al, 1989).
    e) PREVALENCE: Based on several studies, the incidence of systemic allergic reactions after Hymenoptera stings in the general population ranged from 0.15% to 3.3%; 26.5% had IgE antibodies to Hymenoptera venom. It appears that the majority of individuals who have venom IgE antibodies have never experienced an allergic reaction (Charpin et al, 1992; Golden et al, 1989).
    f) RISK FACTORS
    1) Atopy does not increase the incidence of anaphylactic reactions to Hymenoptera stings, although asthmatic patients have more severe reactions to stings than nonatopic patients (Birnbaum et al, 1990a; Settipane & Boyd, 1989). Hymenoptera stings on the head and neck are more prone to elicit generalized reactions than stings on the foot and hand (Graft, 1991).
    2) A risk factor in the development of Hymenoptera venom allergy may be a short interval (less than 2 months) between the innocuous sting and the successive sting (Pucci et al, 1994).
    3) PREDISPOSING CONDITION: Recurrent venom anaphylaxis may occur in approximately 30% of patients with mastocytosis, a condition caused by a monoclonal proliferation of pathological mast cells in different tissues, including skin, bone marrow, liver, spleen, lymph node, and gastrointestinal tract. This condition can result in an increase in severe sting-related anaphylaxis (Merida Fernandez et al, 2014). Hymenoptera stings may produce anaphylactoid shock as a presenting symptom of mastocytosis (Kors et al, 1993).
    a) CASE REPORT: A 43-year-old man with a history of anaphylaxis by sensitization to wasp venom (specific IgE to P dominula) who was receiving immunotherapy to P dominula venom for about a year, presented with a cutaneous eruption (purpura pigmentosa chronica) after experiencing 4 episodes of anaphylaxis following an insect sting (a leaf-cutter bee [genus: Megachile concinna; Hymenoptera; Apoidea; Megachilidae]). A skin prick test was negative using an extract of M concinna bodies. Laboratory results revealed high concentrations of basal serum tryptase, normal levels of IgE, and low specific IgE levels to P dominula. Cytological analysis of bone marrow confirmed the diagnosis of indolent systemic mastocytosis (Merida Fernandez et al, 2014).
    g) LATE-ONSET ALLERGIC REACTIONS: Effects may occur several hours to as long as 10 days after a sting and range from typical anaphylactic and serum sickness-like reactions, including local swelling, urticaria, throat edema, generalized rash, fever, lymphadenopathy, swelling, and arthralgia. These effects may be mediated by venom-specific IgG and venom-specific IgE (Lazoglu et al, 1995; Reisman, 1991; Reisman & Livingston, 1989).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Monitor vital signs, pulse oximetry and continuous cardiac monitoring.
    B) Monitor CBC, basic metabolic profile, liver enzymes, CK, INR, PTT, urinalysis and lactate in patients with multiple stings.
    C) Diagnostic procedures usually involve intradermal tests with various dilutions of Hymenoptera venoms. Most individuals with histories of hypersensitivity to Hymenoptera stings have positive venom skin tests. Whole body extracts of insects are no longer used in this procedure.
    D) The radioallergoabsorbent test (RAST) is an "in vitro" method that measures the quantity of venom-specific antibodies in the patient's serum. It is used as an adjunct to the venom skin test.

Methods

    A) OTHER
    1) Two methods that assist in the detection of IgE-mediated allergic sensitivity to Hymenoptera venom include the venom skin test and the RAST (radioallergosorbent test). These tests also provide information on the taxonomic identity of the stinging insect(s) to which the person is sensitive (Schmidt, 1992).
    a) Confirmation of hypersensitivity is a necessity for venom-allergy treatment, and knowledge of the offending insect species is helpful to design specific treatment.
    2) No diagnostic test presently available predicts with certainty the risk of future systemic reactions or their severity (Engle et al, 1988; (Golden, 1987; King & Valentine, 1987).
    3) VENOM SKIN TESTING - Most widely recommended and validated diagnostic procedure (Golden, 1987). Hymenoptera venoms are commercially available for honeybee, yellow jacket, yellow hornet, white-faced hornet and Polistes wasp. Whole body extracts of these insects are ineffective and no longer recommended for VST (Hoffman & Golden, 1987).
    a) TEST PROCEDURE (Valentine & Golden, 1988) - Intradermal skin tests are performed with venoms diluted to concentrations in the range of 0.001 microgram to 1 microgram/milliliter.
    1) Approximately 90% of individuals with histories of systemic or large local sting reactions will have a positive VST, manifested by a specific wheal and flare reaction to one or more venoms at a concentration of 1 microgram/milliliter or less.
    b) ADVERSE REACTIONS - Allergic systemic reactions are associated with VST, but these are generally infrequent and rarely severe (Lockey et al, 1989). Patients should not be skin tested until 2 to 4 weeks after a Hymenoptera sting (Anon, 1988; Barsky, 1987).
    4) RAST - An in vitro method that measures the quantity of venom-specific IgE antibodies in the patient's serum.
    a) Recommended as an adjunct to VST for the diagnosis of sting allergy (Reisman & Livingston, 1992).
    b) ACCURACY - Less sensitive, more time-consuming, and more expensive than VST. In one study, 20% of subjects with positive VST had a negative RAST and 10% to 15% of subjects with a positive RAST had a negative VST (Golden, 1987).
    c) HISTORY - In addition to objective evidence of IgE antibodies provided by VST or RAST, the diagnosis and management of insect sting allergy require a clear history of a systemic sting reaction, including classification of the reaction, identification of the offending insect, general patient characteristics such as occupation and co-existing disease (Li & Yungingen, 1992; (Reisman & Livingston, 1992; Thompson et al, 1989).
    5) Patients eligible for these tests should be referred to an allergist-immunologist experienced in this methodology (Anon, 1988).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.6) DISPOSITION/BITE-STING EXPOSURE
    6.3.6.1) ADMISSION CRITERIA/BITE-STING
    A) Those patients who develop severe anaphylaxis require admission and continued monitoring for late development of symptoms even after therapy is administered. Patients with evidence of hemolysis, rhabdomyolysis or systemic effects after multiple stings should be admitted. Patients with laboratory abnormalities or signs and symptoms other than local pain should be admitted.
    6.3.6.2) HOME CRITERIA/BITE-STING
    A) Patients with a small number of stings, who do not develop evidence of an allergic reaction, can be managed at home. Manually remove the sting shafts with their commonly attached venom sacs as soon as possible. If possible, use a key, piece of cardboard or other blunt-edged device. Avoid squeezing the stinger or venom sac. Local application of ice packs at the sting site for 15 minutes every 30 minutes may decrease the intensity of swelling. Over the counter antihistamines may reduce pruritus and swelling.
    6.3.6.3) CONSULT CRITERIA/BITE-STING
    A) Consult a poison center or medical toxicologist for assistance in managing patients with severe signs and symptoms.
    6.3.6.5) OBSERVATION CRITERIA/BITE-STING
    A) Any patient sustaining 50 stings or more should be observed for at least 6 hours with laboratory evaluation on presentation and at the end of observation for hemolysis, thrombocytopenia, liver and renal function abnormalities, increased CK and rhabdomyolysis (Kolecki, 1999). Patients with multiple stings who look well after 6 to 8 hours observation and have normal laboratory evaluations can be discharged but should have repeat laboratory evaluation in 24 to 48 hours to detect delayed effects.

Monitoring

    A) Monitor vital signs, pulse oximetry and continuous cardiac monitoring.
    B) Monitor CBC, basic metabolic profile, liver enzymes, CK, INR, PTT, urinalysis and lactate in patients with multiple stings.
    C) Diagnostic procedures usually involve intradermal tests with various dilutions of Hymenoptera venoms. Most individuals with histories of hypersensitivity to Hymenoptera stings have positive venom skin tests. Whole body extracts of insects are no longer used in this procedure.
    D) The radioallergoabsorbent test (RAST) is an "in vitro" method that measures the quantity of venom-specific antibodies in the patient's serum. It is used as an adjunct to the venom skin test.

Oral Exposure

    6.5.3) TREATMENT
    A) SUPPORT
    1) See the bite/stings section for further treatment information.

Enhanced Elimination

    A) PLASMAPHERESIS
    1) A 30-year-old man, who received more than 2000 stings from Africanized bees and subsequently developed multiorgan failure, recovered without sequelae following supportive care and treatment with peritoneal dialysis and plasmapheresis. Plasmapheresis was initiated on day 3 and repeated every other day for a total of 3 times The authors suggested that early intervention with plasmapheresis may have contributed to the clinical improvement in massive bee envenomation (Diaz-Sanchez et al, 1998). It is believed that plasmapheresis either directly reduces the massive amounts of circulating venom or removes the circulating inflammatory mediators that are potentially elicited by the venom itself (Beccari, 1999).

Summary

    A) The range of toxicity from a nonimmunologic reaction is venom dose-dependent and extends from trivial to death in the case of massive attacks.
    B) In toddlers, as few as 7 stings have caused systemic effects. Twenty or more stings from vespid Hymenoptera (eg, wasps) may cause severe morbidity or death. Although more than 1000 honeybee stings have been incurred with survival, 150 or more honey bee stings have caused severe morbidity and death. One man who endured more than 2000 Africanized bee stings survived without sequelae despite multiple organ failure.
    C) Massive attacks by bees can result in up to several thousand stings, while massive wasp attacks range from ten to hundreds of stings.

Minimum Lethal Exposure

    A) SPECIFIC SUBSTANCE
    1) Mass envenomating attacks by Hymenoptera result in direct poisoning, the toxic effects being due to the venom itself rather than the body's immune system reacting to the venom (Schmidt, 1992).
    2) Thirty or more stings by vespid Hymenoptera (eg, wasps) or 500 or more Africanized bee stings may cause severe morbidity or death (Beccari et al, 1992; Munoz-Arizpe et al, 1992; Schmidt, 1992). In a review of Hymenoptera stings, Vetter et al (1999) stated that renal failure or death could occur in the range of 20 to 200 wasp stings and 150 to 1500 honey bee stings. One man who endured more than 2000 Africanized bee stings survived without sequelae despite multiple organ failure (Diaz-Sanchez et al, 1998).
    a) The human LD50 for honey bee stings was estimated to be between 500 to 1200 stings (Vetter et al, 1999). Kim et al (1999) estimated the human LD50 to be 19 honey bee stings per kilogram body weight.
    3) Because of their smaller size, children and infants may be subject to lethal envenomation by fewer stings than adults, although the data is variable.
    4) 1 to 4 Hymenoptera stings may cause severe morbidity or death due to a systemic allergic reaction (Theil, 1992).
    5) The most frequent wasp species causing human death due to massive attacks are reported to be Vespa orientalis and Vespa affinis in the eastern hemisphere (Vetter et al, 1999).

Maximum Tolerated Exposure

    A) ADULT: A 73-year-old woman with no known allergies was stung 518 times by a swarm of bees. One day later she was found unresponsive at home with massive soft tissue swelling, severe hypertension, and signs of pulmonary congestion. Despite supportive care, her condition deteriorated and she developed severe rhabdomyolysis, toxic hepatitis, and acute renal failure. Following further symptomatic therapy, including 7 sessions of hemodialysis, her condition gradually improved. After 20 days in an acute care hospital she was discharged to a nephrology clinic where she subsequently developed hemorrhagic gastritis with melena. She remained in this facility for 12 days and was discharged. On a follow-up visit 6 months later, she had compensated polyarthrosis and hypertension (Iliev et al, 2010).
    B) PEDIATRICS: A 3-year-old boy sustained almost 90 stings on his abdomen and 30 on his chest, abdomen, back and extremities after he and his father were attached by a swarm of yellow jackets. The child presented to the hospital via emergency medical transport after the event and developed elevated liver enzymes, elevated creatine kinase and decreased white blood cells and was treated with standard care. He was discharged two days after hospitalization without further sequelae(West et al, 2011).
    C) PEDIATRICS: A 3.5-year-old boy developed seizures, hypoglycemia, elevated liver enzymes, rhabdomyolysis, acute renal failure requiring temporary dialysis, anemia and clotting abnormalities after an estimated 6 or 7 stings by yellow jackets. He recovered with supportive care (Broides et al, 2010).

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) References: Schmidt, 1990
    B) References: Schmidt, 1990
    C) References: Schmidt, 1990
    D) References: Schmidt, 1990
    E) References: Schmidt, 1990
    F) References: Schmidt, 1990
    G) References: Schmidt, 1990
    H) References: Schumacher et al, 1990
    I) References: Schumacher et al, 1990

Toxicologic Mechanism

    A) GENERAL
    1) Venoms of the Hymenoptera are mixtures of several antigens, nonimmunologic small peptides, and vasoactive amines (Schmidt, 1992; King & Valentine, 1987).
    B) Known protein and peptide components in honeybee and vespid venoms (Schmidt, 1992; King, 1990):
    1) Honeybee venom: Proteins: Phospholipase A-2; Hyaluronidase; Acid phosphatase. Peptides: Melittin, Apamin, MCD peptide
    2) Vespid venom: Proteins: Phospholipase A, B; Hyaluronidase, Antigen 5. Peptides: Kinin, Mastoparan.
    C) ALLERGENS
    1) The 3 major allergens in honeybee venom are the proteins phospholipase A-2, hyaluronidase, and acid phosphatase. In vespids, the major allergenic components are the proteins phospholipase A, B, hyaluronidase, and Antigen 5 (Schmidt, 1992; Golden, 1987; Nakajima, 1986).
    2) Africanized honeybee venom contains almost 20% more phospholipase A-2 (a major allergen) than European honeybee venom (Schumacher et al, 1992).
    D) CROSSREACTIVITY: Considerable immunologic crossreactivity exists among vespid species (King & Valentine, 1987), but there appears to be a low cross-relactivity between vespid and bee venoms (Reisman et al, 1984).
    E) NATURAL IMMUNITY: When natural immunity to Hymenoptera venom develops, it is usually due to the development of large amounts of IgG antibodies which block the combination of venom antigen with IgE and prevents or lessens immunologic response (Wongsiri et al, 1987).
    F) MELITTIN
    1) Peptide present in relatively high concentrations in bee venom. It is responsible for much of the local pain caused by bee stings and alters membrane integrity (Prince et al, 1985; Vetter et al, 1999). Africanized honeybee venom contains a low concentration of mellitin in comparison to European honeybee venom (Schumacher, 1992).
    2) Direct hemolysin and can induce rabbit platelets to aggregate (Yu & Xiong, 1990); also has cell surface-active properties that are related to its hemolytic action (King & Valentine, 1987).
    3) Has been investigated for its effect in lowering blood cholesterol and lipids (Qian et al, 1990a).
    G) PHOSPHOLIPASE A2: After mellitin has disrupted the cell membrane, phospholipase A2 works to induce red-cell hemolysis by cleaving bonds in the cell membrane (Vetter et al, 1999).
    H) MAST CELL DEGRANULATING PEPTIDES exist in honeybee venom (MCD peptide) and in vespid venom (mastoparan); results in mast cell release of histamine (Schmidt, 1991; King, 1990; Vetter et al, 1999).
    I) HYALURONIDASE: In addition to acting as an allergen, it causes disruption of the hyaluronic acid connective tissue matrix, thus allowing for spread of venom into tissue (Vetter et al, 1999).
    J) APAMIN: Peptide neurotoxin found in relatively low concentrations in honeybee venom; has a profound effect on spinal cord function, causing hyperactivity, muscle spasms and seizures (Banks & Shipolini, 1986).
    K) NONALLERGIC AMINES
    1) Hymenoptera venoms contain nonallergenic amines, which include acetylcholine, histamine, and catecholamines in bee venom, and histamine, catecholamines, and serotonin in vespid venom. Vespid venoms also contain kinins, peptides similar to bradykinin, which are responsible for most of the pain associated with wasp stings. These venom components have inflammatory and vasoactive properties that contribute to the normal local reaction to a sting and may hasten absorption of venom allergens (Golden, 1987).
    L) FIBRINOLYTIC ACTIVITY has been identified in several bee venoms (Xiong et al, 1990). Both prothrombin and thromboplastin are inhibited by bee venom (Qian et al, 1990b).

General Bibliography

    1) Agostinucci W, Cardoni AA, & Rosenberg P: Effect of papain on bee venom toxicity. Toxicon 1981; 19:851-855.
    2) An JY, Kim JS, Min JH, et al: Hemichorea after multiple bee stings. Am J Emerg Med 2014; 32(2):196-.
    3) Anon : Department of Pharmacology - University of Melbourne. Department of Pharmacology, University of Melbourne. Melbourne, Australia. 2001a. Available from URL: http://www.pharmacology.unimelb.edu.au/.
    4) Anon: Local Government Association of South Australia. Local Government Association of South Australia. Adelaide, South Australia. 2001b. Available from URL: http://www.lga.sa.gov.au/site/page.cfm. As accessed corrected URL, added city/state & publisher.
    5) Anon: Stings of flying insects. Emerg Med 1988; 20:92-111.
    6) Arcieri ES, Franca ET, de Oliveria HB, et al: Ocular lesions arising after stings by hymenopteran insects. Cornea 2002; 21(3):328-330.
    7) Awai L & Mekori YA: Insect sting anaphylaxis and beta-adrenergic blockage: a relative contraindication. Ann Allergy 1984; 53:48-49.
    8) Balit CR, Isbister GK, & Buckley NA: Randomized controlled trial of topical aspirin in the treatment of bee and wasp stings. J Toxicol Clin Toxicol 2003; 41(6):801-808.
    9) Banks BEC & Shipolini RA: Biochemistry and pharmacology of honeybee venom. In: Piek T (Ed): Venoms of the Hymenoptera: Biochemical, Pharmacological and Behavioural Aspects, Academic Press, Orlando, FL, 1986, pp 330-403.
    10) Banovcin P , Havlicekova Z , Jesenak M , et al: Severe quadriparesis caused by wasp sting. Turk J Pediatr 2009; 51(5):485-488.
    11) Barsky HE: Stinging insect allergy: avoidance, identification, and treatment. Postgrad Med J 1987; 82:157-162.
    12) Beccari M, Castiglione A, & Vavaliere G: Unusual case of anurai due to African bee stings. Int J Artif Organs 1992; 15:281-283.
    13) Beccari M: Dialysis or plasmapheresis for acute renal failure due to Africanized honeybee stings (letter). Arch Intern Med 1999; 159:1255-1256.
    14) Bernard AA & Kersley JB: Sensitivity to insect stings in patients taking antiinflammatory drugs. Br Med J 1986; 292:378-379.
    15) Bernstein DI, Mittman RJ, & Kagen SL: Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera sensitive patients. J Allergy Clin Immunol 1989; 84:951-959.
    16) Bernstein JA, Kagen SL, & Bernstein DI: Rapid venom immunotherapy is safe for routine use in the treatment of patients with hymenoptera anaphylaxis. Ann Allergy 1994; 73:423-428.
    17) Betten DP, Richardson WH, Tong TC, et al: Massive honey bee envenomation-induced rhabdomyolysis in an adolescent. Pediatrics 2006; 117(1):231-235.
    18) Birnbaum D, Charpin D, & Vervolet D: Rapid hymenoptera venom immunotherapy: comparative safety of three protocol. Clin Exp Allergy 1993; 23:226-230.
    19) Birnbaum J, Vervloet D, & Lagier F: Atopy and systemic reactions to Hymenoptera stings (Abstract). J Allergy Clin Immunol 1990a; 85:212.
    20) Bousquet J, Huchard G, & Michel FB: Toxic reaction induced by hymenoptera venom. Ann Allergy 1984; 52:371-374.
    21) Bousquet J, Menardo JL, & Velasquez: Systemic reactions during maintenance immunotherapy with honeybee venom. Ann Allergy 1988; 61:63-68.
    22) Bousquet J, Muller UR, & Dreborg S: Immunotherapy with Hymenoptera venoms. Allergy 1987; 42:401-413.
    23) Broides A, Maimon MS, Landau D, et al: Multiple hymenoptera stings in children: clinical and laboratory manifestations. Eur J Pediatr 2010; 169(10):1227-1231.
    24) Butterton JR & Clawson-Simons J: Hymenoptera uvulitus. N Engl J Med 1987; 317:1291.
    25) Casale TB: Histamine H-1 and H-2 receptors. NER Allergy Proc 1984; 5:311-316.
    26) Charpin D, Birnbaum J, & Lanteaume A: Prevalence of allergy to Hymenoptera stings in different samples of the general population. J Allergy Clin Immunol 1992; 90:331-334.
    27) Chen CJ & Richardson CD: Bee sting-induced ocular changes. Ann Ophthalmol 1986; 18:285-286.
    28) Chen DM, Lee PT, Chou KJ, et al: Descending aortic thrombosis and cerebral infarction after massive wasp stings (letter). Am J Med 2004; 116:567-569.
    29) Chinwattanakul S, Prabhasawat P, & Kongsap P: Corneal injury by bee sting with retained stinger--a case report. J Med Assoc Thai 2006; 89(10):1766-1769.
    30) Corren J & Schocket AL: Anaphylaxis-a preventable emergency. Postgrad Med J 1990; 87:167-173.
    31) Deshmukh LS & Borse BT: Acute renal failure following multiple stings by honeybees. Indian Pediatr 1996; 33:781-783.
    32) Diaz-Sanchez CL, Lifshitz-Guinzberg A, & Ignacio-Ibarra G: Survival after massive (>2000) Africanized honeybee stings. Arch Intern Med 1998; 158:925-927.
    33) Dionne AJ, Griffith A, Levin M, et al: Exacerbation of multiple sclerosis following wasp stings. Mayo Clin Proc 2000; 75:317-318.
    34) El Husseiny M, Karam L, Maalouly G, et al: Severe lower limb ischemia after bee stings. Ann Vasc Surg 2011; 25(2):269.e5-269.e-7.
    35) Elgart GW: Ant, bee, and wasp stings. Dermatol Clin 1990; 8:229-236.
    36) Franca FOS, Benvenuti LA, & Fan HW: Severe and fatal mass attacks by "killer" bees (Africanized honey bees--Apis mellifera scutellata) in Brazil: clinicopathological studies with measurement of serum venom concentrations. Q J Med 1994; 87:269-282.
    37) Freye HB & Ehrlich B: Acute myocardial infarction following Hymenoptera envenomation (Abstract). J Allergy Clin Immunol 1989; 83:230.
    38) Fricker M, Helbling A, & Schwartz L: Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 1997; 100:11-15.
    39) Friis EV, Fredericksen M, & Simonsen E: Anaphylactic reaction during immunotherapy related to alcohol consumption. Allergy 1992; 47:123-124.
    40) Golden DB & Valentine MD: Insect sting allergy. Ann Allergy 1984; 53:444-449.
    41) Golden DBK, Kurterovich KA, & Valentine MD: Risk benefit of discontinuing venom immunotherapy (VIT) after 5 years (abstract). J Allergy Clin Immunol 1991; 87:237.
    42) Golden DBK, Marsh DG, & Sobotka AK: Epidemiology of insect venom sensitivity. JAMA 1989; 262:240-244.
    43) Golden DBK: Diagnosis and prevalence of stinging insect allergy. Clin Rev Allergy 1987; 5:119-136.
    44) Goldstein NP, Rucker CW, & Woltman HW: Neuritis occurring after insect stings. JAMA 1960; 173:1727-1730.
    45) Graft DF & Schoenwetter WF: Insect sting allergy: analysis of a cohort of patients who initiated venom immunotherapy from 1978 to 1986. Ann Allergy 1994; 73:481-485.
    46) Graft DF: Stinging insect hypersensitivity in children. Curr Opin Pediatr 1996; 8:597-600.
    47) Graft DF: Venom immunotherapy for stinging insect allergy. Clin Rev Allergy 1987; 5:149-159.
    48) Graft DF: When to start, when to stop, and what to measure in venom immunotherapy: issues in allergy grand seminal, AAAI annual meeting 1990. J Allergy Clin Immunol 1991; 88:409-413.
    49) Haga N, Masuda K, & Takikawa K: Osteochondral destruction in the hand following bee stings: a case report of an infant. Hand Surg 2006; 11(3):143-145.
    50) Harris MW & Valentine MD: Yellow jacket sting in a patient taking propranolol and quinidine therapy. JAMA 1981; 245:1767.
    51) Haugaard L, Norregaard O, & Dahl R: In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy. J Allergy Clin Immunol 1991; 87:699-702.
    52) Hauk P, Friedl K, & Kaufmehl K: Subsequent insect stings in children with hypersensitivity to Hymenoptera. J Pediatr 1995; 126:185-190.
    53) Hay SM, Hay FA, & Austwick DH: Bee sting brachial block. Arch Int Med 1992; 9:369-372.
    54) Henderson D & Easton RG: Stingose. A new and effective treatment for bites and stings. Med J Aust 1980; 2:146-150.
    55) Hermes B, Haas N, & Grabbe J: Foreign-body granuloma and IgE-pseudolymphoma after multiple bee stings. Br J Dermatol 1994; 130:780-784.
    56) Hoffman DR & Golden DBK: Standardized extracts: stinging and biting insects. Clin Rev Allergy 1987; 5:75-88.
    57) Holgate ST & Church MK: Allergy, 27, Raven Press, New York, NY, 1993, pp 1-27&-29.
    58) Hur W, Ahn SK, & Lee SH: Cutaneous reaction induced by retained bee stinger. J Dermatol 1991; 18:736-739.
    59) Iliev YT , Tufkova SG , & Prancheva MG : A rare case of severe intoxication from multiple bee stings with a favorable outcome. Folia Med (Plovdiv) 2010; 52(3):74-77.
    60) Ingall M, Goldman G, & Page LB: Beta-blockade in stinging insect anaphylaxis. JAMA 1984; 251:1432.
    61) Jerrard DA: ED management of insect stings. Am J Emerg Med 1996a; 14:429-433.
    62) Jerrard DA: ED management of insect stings.. Am J Emerg Med 1996; 14:429-433.
    63) Jones E & Joy M: Acute myocardial infarction after a wasp sting. Br Heart J 1988; 59:506-508.
    64) Kaliner MA: Anaphylaxis. NER Allergy Proc 1984; 5:324-328.
    65) Keating MU, Kagey=Sobotka A, & Hamilton RG: Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 1991; 88:339-348.
    66) Kim JM, Kang SJ, Kim MK, et al: Corneal wasp sting accompanied by optic neuropathy and retinopathy. Jpn J Ophthalmol 2011; 55(2):165-167.
    67) Kim KT & Oguro J: Update on the status of africanized honey bees in the western states. West J Med 1999; 170:220-222.
    68) King & Valentine: Allergens of hymenoptera venoms. Clin Rev Allergy 1987; 5:137-148.
    69) King TP: Insect venom allergies. In: Baldo BA (Ed): Molecular Approaches to the Study of Allergens, S Karger AG, Basel, Switzerland, 1990, pp 84-100.
    70) Kini PG, Baliga M, & Bhaskaranand N: Severe derangement of the coagulation profile following multiple bee stings in a 2-year-old boy. Ann Trop Paediatr 1994; 14:153-155.
    71) Kivity S & Yarchousky JK: Relapsing anaphylaxis to bee sting in a patient treated with beta-blocker and calcium blocker. J Allergy Clin Immunol 1990; 85:669-670.
    72) Kochuyt AM & Stevens EAM: Safety and efficacy of a 12-week maintenance interval in patients treated with Hymenoptera venom immunotherapy. Clin Exp Allergy 1994; 24:35-41.
    73) Kors JW, Van Doormaal JJ, & De Monchy JGR: Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis. J Intern Med 1993; 233:255-258.
    74) Lanier B: Meat tenderizer and stings (letter). Pediatrics 1982; 69:505-506.
    75) Lazoglu AH, Boglioli LR, & Taff ML: Serum sickness reaction following multiple insect stings. Ann Allergy Asth Immunol 1995; 75:522-524.
    76) Levine HD: Acute myocardial infarction following wasp sting. Am Heart J 1976; 91:365-374.
    77) Li JTC & Yunginger JW: Management of insect sting hypersensitivity. Mayo Clin Proc 1992; 67:188-194.
    78) Lieberman P, Nicklas R, Randolph C, et al: Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol 2015; 115(5):341-384.
    79) Lieberman P, Nicklas RA, Oppenheimer J, et al: The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126(3):477-480.
    80) Lieberman P: The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reactions. J Allergy Clin Immunol 1990; 86:684-686.
    81) Lin CJ, Wu CJ, Chen HH, et al: Multiorgan failure following mass wasp stings. South Med J 2011; 104(5):378-379.
    82) Lin PH, Wang NK, Hwang YS, et al: Bee sting of the cornea and conjunctiva: management and outcomes. Cornea 2011a; 30(4):392-394.
    83) Lindzon RD & Silvers WS: Anaphylaxis. In: Rosen P, Baker FJ II, Barken RM et al (Eds): Emergency Medicine Concepts and Clinical Practice, CV Mosby Co, St. Louis, MO, 1988, pp 203-231.
    84) Livingston A & Reisman R: Venom immunotherapy (VIT); ten years experience with administration of single venoms and 50 microgram maintenance doses (Abstract). J Allergy Clin Immunol 1990; 85:210.
    85) Lockey RF, Hubbard JM, & Bukantz SC: The Hymenoptera venom study III: safety of venom immunotherapy. J Allergy Clin Immunol 1990; 86:775-780.
    86) Lockey RF, Turkeltaub PC, & Baird-Warren IA: The Hymenoptera study I, 1979-1982: demographics and history-sting data. J Allergy Clin Immunol 1988; 82:370-380.
    87) Lockey RF, Turkeltaub PC, & Olive CA: The Hymenoptera study II: skin test results and safety of venom skin testing. J Allergy Clin Immunol 1989; 84:967-974.
    88) Lomnitzer R, Lanner A, & Rabson AR: Low specific IgE, IgG, and lymphocyte reactivity in a group of patients developing anaphylaxis following a honeybee sting. Clin Allergy 1988; 18:39-44.
    89) Marquardt DL & Wasserman SI: Anaphylaxis. In: Middleton E, Reed CE, Eliss EF et al (Eds) Allergy: Principles and Practice, Vol II, 4th ed, Mosby, St Louis, MO, 1993, pp 1511-1521.
    90) Mazza JA, Moote DW, & Gamble JB: Memory loss and pneumonitis after anaphylaxis due to an insect sting. Can Med Assoc J 1991; 144:175-176.
    91) McGain F, Harrison J, & Winkel KD: Wasp sting mortality in Australia. Med J Aust 2000; 173:198-200.
    92) McKenna WR: Stinging insect allergy. Allergy Proc 1992; 76:883-894.
    93) McLean DC: Insect sting allergy. Immunol Allergy Pract 1987; 9:171-177.
    94) Means ED, Barron KD, & Van Dyne BJ: Nervous system lesions after sting by yellow jacket. Neurology 1973; 23:881-890.
    95) Meija G, Arbelaez M, & Henao JE: Acute renal failure due to multiple stings by Africanized bees. Ann Int Med 1986; 104:210-211.
    96) Merida Fernandez C, Carreno Rojo A, Iraola V, et al: Recurrent anaphylaxis associated with solitary bee sting (Hymenoptera: Megachilidae) in a patient with mastocytosis. J Investig Allergol Clin Immunol 2014; 24(3):196-197.
    97) Meszaros I: Shwartzman reaction in children caused by mass bee (Apis mellifica) venom (Abstract). J Toxicol Toxin Rev 1990; 9:61.
    98) Miyashita K: Wasp-sting-induced linear keratitis. Ann Ophthalmol 1992; 24:143-145.
    99) Moscati RM & Moore GP: Comparison of cimetidine and diphenhydramine in the treatment of urticaria. Ann Emerg Med 1990; 19:12-14.
    100) Mulfinger L, Yunginger J, & Styer W: Sting morphology and frequency of sting autotomy among medically important vespids (Hymenoptera: vespidae) and the honey bee (Hymenoptera: Apidae). J Med Entomol 1992; 29:325-328.
    101) Muller U, Berchtold E, & Helbing A: Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 1991; 87:702-709.
    102) Muller U, Helbing A, & Berchtold E: Immunotherapy with honeybee venom and yellow jacket venom is different regarding safety and efficacy. J Allergy Clin Immunol 1992; 89:529-535.
    103) Muller U, Helbling A, & Berchtold E: Are there differences between hypersensitivity to honey bee venom and to vespula venom? (abstract). J Allergy Clin Immunol 1990; 85:211.
    104) Muller U, Stettler R, & Hottinger S: Cardiac symptoms during anaphylaxis to Hymenoptera stings (Abstract). J Allergy Clin Immunol 1989; 83:230.
    105) Munoz-Arizpe R, Valencia-Espinosa L, & Velasquez-Jones L: Africanized bee stings and pathogenesis of acute renal failure. Nephron 1992; 61:478.
    106) Nace L: Multiple European wasp stings and acute renal failure. nephron 1992; 61:477.
    107) Nakajima R: Pharmacological biochemistry of vespid venoms. In: Piek T (Ed): Venoms of the Hymenoptera: Biochemical, Pharmacological and Behavioural Aspects, Academic Press, Orlando, FL, 1986, pp 309-324.
    108) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    109) Norman PS & van Metre TE: The safety of allergic immuno-therapy. J Allergy Clin Immunol 1990; 85:522-525.
    110) Nowak RM & Macias CG : Anaphylaxis on the other front line: perspectives from the emergency department. Am J Med 2014; 127(1 Suppl):S34-S44.
    111) Orletsky P & Thomas R: Profile of multiple bee envenomations. Clin Toxicol 2000b; 38(5):511.
    112) Orletsky P & Thomas R: Risk factors for adverse effects in multiple bee envenomations. Clin Toxicol 2000a; 38(5):511-512.
    113) Otero E, Onufer JR, & Reiss CK: Anaphylaxis-induced myocardial depression treated with amrinone. Lancet 1991; 337:682-683.
    114) Petersen DL: Hymenoptera stings and beta-blockers. Lancet 1989; 2:619.
    115) Prince RC, Gunson DE, & Scarpa A: Sting like a bee! The ionophoric properties of melittin. TiBS 1985; 10:99.
    116) Product Information: diphenhydramine HCl intravenous injection solution, intramuscular injection solution, diphenhydramine HCl intravenous injection solution, intramuscular injection solution. Hospira, Inc. (per DailyMed), Lake Forest, IL, 2013.
    117) Pucci S, Antonicelli L, & Bilo MB: Shortness of interval between two stings as risk factor for developing Hymenoptera venom allergy. Allergy 1994; 49:894-896.
    118) Qian R, Tian K, & Yang R: Effects of melittin on lipemia (Abstract). J Toxicol Toxin Rev 1990a; 9:62.
    119) Qian R, Tian K, & Yang R: Fractionation of bee (Apis mellifera) venom by chromatography and its anticoagulant action (Abstract). J Toxicol Toxin Rev 1990b; 9:63-64.
    120) Raucq E & Dupuis MJM: Facial diplegia after Hymenoptera sting. Acta Neurol Belg 1998; 98:215-220.
    121) Reisman RE & Livingston A: Late-onset allergic reactions, including serum sickness after insect stings. J Allergy Clin Immunol 1989; 84:331-337.
    122) Reisman RE & Livingston A: Venom immunotherapy: 10 years of experience with administration of single venoms and 50 microgram maintenance doses. J Allergy Clin Immunol 1992; 89:1189-1195.
    123) Reisman RE: Unusual reactions to insect venom. Allergy Proc 1991; 12:395-399.
    124) Reisman RE: Venom hypersensitivity. J Allergy Clin Immunol 1994; 94:651-658.
    125) Rekik S, Andrieu S, Aboukhoudir F, et al: ST elevation myocardial infarction with no structural lesions after a wasp sting. J Emerg Med 2009; Epub:Epub-.
    126) Saini AG: Acute axonal polyneuropathy following honey-bee sting: a case report. J Child Neurol 2014; 29(5):674-676.
    127) Sakhuja V, Bhalla A, & Pereira BJG: Acute renal failure following multiple hornet stings. Nephron 1988; 49:319-321.
    128) Schellenberg RR, Bramble SE, & Graham RE: Histamine-2 antagonist inhibits increases in heart rate and norepinephrine by histamine (Abstract). J Allergy Clin Immunol 1989; 83:309.
    129) Schmidt JO, Blum MS, & Overall WL: Comparative enzymology of venoms from stinging hymenoptera. Toxicon 1986; 24:907-921.
    130) Schmidt JO: Allergy to venomous insects. In: Graham J (ED): The Hive and the Honeybee, Dadant & Son, Hamilton, IL, 1992, pp 1209-1269.
    131) Schmidt JO: Allergy to venomous insects. In: Graham J (Ed): The Hive and the Honeybee, Dadant & Son, Hamilton, IL, 1991, pp 1-90.
    132) Schmidt JO: Hymenoptera venoms: striving toward the ultimate defense against vertebrates, In: Evans DL & Schmidt JO (Ed): Insect Defenses: Adaptive mechanisms and Strategies of Prey and Predators, State University of Press, Albany, New York, NY, 1990, pp 387-419.
    133) Schoen EJ: Temporal arteritis after Hymenoptera sting (letter). J Rheumatol 1998; 25:2040-2041.
    134) Schumacher MJ, Schmidt JO, & Egen NB: Biochemical variability of venoms from individual European and Africanized honeybees. J Allergy Clin Immunol 1992; 90:59-65.
    135) Schumacher MJ, Schmidt JO, & Egen NB: Quantity, analysis, and lethality of European and Africanized honey bee venoms. Am J Trop Med Hyg 1990; 43:79-86.
    136) Schumacher MJ, Tveten MS, & Egen NB: Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol 1994; 93:831-835.
    137) Schwartz HJ, Golden DBK, & Lockey RF: Venom immunotherapy in the Hymenoptera-allergic pregnant patient. J Allergy Clin Immunol 1990; 85:709-712.
    138) Settipane GA & Boyd GK: Anaphylaxis from insect stings: myths, controversy, and reality. Postgrad Med J 1989; 86:273-281.
    139) Shah D & Tsang TK: Bee sting dysphagia (letter). Ann Intern Med 1998; 129:253.
    140) Sharma AK, Sharma RC, & Sharma NL: Diffuse hair loss following multiple honeybee stings (letter). Dermatol 1997; 305.
    141) Shatz GS: Anaphylaxis. In: Korenblot PE and Wedner HJ (Eds). Allergy Theory and Practice, 2nd ed, WB Saunders, Philadelphia, PA, 1992, pp 229-241.
    142) Singh G: Bee sting of the cornea. Ann Ophthalmol 1984; 16:320-322.
    143) Singh S, Rattan A, & Kumar S: Severe cutaneous Mycobacterium chelonei infection following a yellow jacket sting. Tubercle Lung Dis 1992; 73:305-309.
    144) Smolin G & Wong I: Bee sting of the cornea: case reports. Ann Opthalmol 1981; 83:230.
    145) Song H & Wray SH: Bee sting optic neuritis. J Clin Neuroophthalmol 1991; 11:45-49.
    146) Soto-Aguilar MC, deSharo RD, & Waring NP: Anaphylaxis. Postgrad Med 1987; 82:154-170.
    147) Speach DP, Wong TM, & Cattarin JA: Hypoxic brain injury with motor apraxia following an anaphylactic reaction to Hymenoptera venom. Brain Inj 1998; 12:239-244.
    148) Stablein JJ & Lockey RF: Adverse reactions to ant stings. Clin Rev Allergy 1987; 5:161-175.
    149) Tarhini H, Knani J, & Michel FB: Safety of venom immunotherapy administered by a cluster schedule. J Allergy Clin Immunol 1992; 89:1198-1199.
    150) Temizoz O, Celik Y, Asil T, et al: Stroke due to bee sting. Neurologist 2009; 15(1):42-43.
    151) Thiel JA: Hymenoptera sensitivity. In: Korenblat PE and Wedner HJ (Eds): Allergy. Theory and Practice, 2nd ed, WB Saunders, Philadelphia, PA, 1992, pp 527-539.
    152) Thompson RA, Bousquet J, & Frei PC: The current status of allergen immunotherapy (hyposensitisation): report of a WHO (IUIS) working group. Allergy 1989; 44:369-379.
    153) Vachvanichsanong P & Dissaneewate P: Acute renal failure following wasp sting in children. Eur J Pediatr 2009; Epub:--.
    154) Valentine MD & Golden DBK: Insect venom allergy. In: Samter M, Talmage DW, Frank MM et al (Eds): Immunologic Diseases, Vol 2, 4th ed, Little, Brown, Boston, Mass, 1988, pp 1173-1184.
    155) Valkanas MA, Bowman S, & Dailey MW: Electrocardiographic myocardial infarction without structural lesion in the setting of acute hymenoptera envenomation. Am J Emerg Med 2007; 25(9):1082-1088.
    156) Van der Linden PW, Hack CE, & Poortman J: Insect-sting challenge in 138 patients: Relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 1992; 90:110-118.
    157) Vanden Hoek,TL; Morrison LJ; Shuster M; et al: Part 12: Cardiac Arrest in Special Situations 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. American Heart Association. Dallas, TX. 2010. Available from URL: http://circ.ahajournals.org/cgi/reprint/122/18_suppl_3/S829. As accessed 2010-10-21.
    158) Vetter RS, Visscher PK, & Camazine S: Mass envenomations by honey bees and wasps. West J Med 1999; 170:223-227.
    159) Vidhate MR, Sharma P, Verma R, et al: Bilateral cavernous sinus syndrome and bilateral cerebral infarcts: A rare combination after wasp sting. J Neurol Sci 2011; 301(1-2):104-106.
    160) Visscher PK, Vetter RS, & Camazine S: Removing bee stings. Lancet 1996; 348:301-302.
    161) Watemberg N, Weizman Z, & Shahak E: Fatal multiple organ failure following massive hornet stings. Clinical Toxicology 1995; 33:471-474.
    162) West PL, McKeown NJ, & Hendrickson RG: Massive hymenoptera envenomation in a 3-year-old. Pediatr Emerg Care 2011; 27(1):46-48.
    163) Wongsiri S, Wongsathuaythong S, & Suwanagul M: Comparison of skin tests for honeybee allergy using venom extracts of Apis mellifera, Apis cerana, and Apis florea in normal persons atopic population and beekeepers. In: Gopalakrishnakone P & Tan CK: Progress in Venom and Toxin Research, National University of Singapore, Kent Ridge, Singapore, 1987.
    164) Xiong Y, Wang W, & Yang C: Preliminary study of several kinds of bee venom (Abstract). J Toxicol Toxin Rev 1990; 9:63.
    165) Yanagawa Y, Morita K, Sugiura T, et al: Cutaneous hemorrhage or necrosis findings after Vespa mandarinia (wasp) stings may predict the occurrence of multiple organ injury: a case report and review of literature. Clin Toxicol (Phila) 2007; 45(7):803-807.
    166) Yao C & Deng JF: Hornet sting: resulted in disseminated intravascular coagulation, epidural hemorrhage, intracerebral hemorrhage, intracerebral hemorrhage and peripheral neuropathy (abstract), EAPCCT XVI International Congress, Vienna, Austria, 1994.
    167) Yu X & Xiong Y: The activation of rabbit platelet induced by melittin from the venom (Apis mellifera) (Abstract). J Toxicol Toxin Rev 1990; 9:62.
    168) Yunginger JW, Nelson DR, & Squillace DL: Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 1991; 36:857-865.
    169) Zhang L, Li Z, Fu P, et al: Hybrid renal replacement treatment in acute pulmonary edema with acute kidney injury following multiple wasp stings: a report of 3 cases. Blood Purif 2010; 30(2):106-107.
    170) van Antwerpen CL, Gospe SM, & Wade NA: Myeloradiculopathy associated with wasp sting. Pediatr Neurol 1988; 4:379-380.
    171) von Witt RJ: Topical aspirin for wasp stings. Lancet 1980; 2:8208.